financetom
Business
financetom
/
Business
/
NFL expected to vote in favor of private equity ownership, CNBC reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NFL expected to vote in favor of private equity ownership, CNBC reports
Aug 29, 2024 4:09 AM

Aug 27 (Reuters) - The owners of the National Football League are expected to allow some private equity firms to buy up to a 10% stake in a team, CNBC reported on Tuesday.

The NFL's 32 owners are to vote at a special league meeting in Eagan, Minnesota, according to CNBC, and the private equity firms intend to commit $12 billion in capital, to be raised inclusive of leverage.

The NFL is the only major North American sports league that prohibits private equity ownership in a franchise. The NBA, NHL, Major League Baseball and Major League Soccer allow their teams to sell a maximum of 30% of equity to a fund.

Firms initially approved by the NFL will include Ares Management ( ARES ) and Arctos Partners, in addition to a consortium comprising Blackstone, Carlyle, CVC and Dynasty Equity, the report stated, citing people familiar with the matter.

Private equity firms Ares Management ( ARES ) and Sixth Street Partners as well as firms that are part of the consortium declined to comment on the report. The NFL and Arctos Partners did not immediately respond to Reuters requests for comment.

The NFL formed a committee last year to explore changes in its ownership rules. Commissioner Roger Goodell said in March the league was "very close to sort of outlining an approach", with "a lot of work to do to take that approach into reality".

The Washington Commanders was the most recent NFL team to be sold, in a record-breaking $6.05-billion deal.

With team valuations on the rise, private equity could turn out to be an alternative avenue for future league franchise sales.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
USTR proposes charging Chinese ships up to $1.5 million to enter US ports
USTR proposes charging Chinese ships up to $1.5 million to enter US ports
Feb 24, 2025
WASHINGTON (Reuters) - The U.S. Trade Representative's office has proposed charging up to $1.5 million for Chinese-built vessels entering U.S. ports as part of its investigation into China's growing domination of the global shipbuilding, maritime and logistics sectors. USTR said in a January 16 report on a probe launched during the administration of former President Joe Biden that China increased...
--Willis Towers Watson Increases Quarterly Dividend to $0.92 Per Share From $0.88; Payable April 15 to Holders as of March 31
--Willis Towers Watson Increases Quarterly Dividend to $0.92 Per Share From $0.88; Payable April 15 to Holders as of March 31
Feb 24, 2025
03:00 PM EST, 02/24/2025 (MT Newswires) -- Price: 329.60, Change: +3.65, Percent Change: +1.12 ...
Vertiv Holdings Unusual Options Activity For February 24
Vertiv Holdings Unusual Options Activity For February 24
Feb 24, 2025
Deep-pocketed investors have adopted a bearish approach towards Vertiv Holdings ( VRT ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in VRT usually suggests something big is about to happen. We gleaned this information...
Regeneron's gene therapy study shows improved hearing in children with congenital deafness
Regeneron's gene therapy study shows improved hearing in children with congenital deafness
Feb 24, 2025
By Puyaan Singh Feb 24 (Reuters) - Regeneron Pharmaceuticals ( REGN ) said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between 10 months and 16 years old born with hearing loss caused by gene mutations. The first child in the study to receive Regeneron's therapy, who was dosed at 10 months of age,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved